Structural readiness
Track the exact protein structure, construct, cofactors, ligand pose, and preparation context required by the calculation.
RBFE and ABFE workflows
Qualify the protein-ligand system, map ligand transformations, submit configured free energy calculations, and review estimates with uncertainty, convergence context, and the artifacts needed to challenge the result.
Prerequisites before compute
MolexIO ties each run to an exact target structure, selected pocket or complex, ligand identities, mapping, method, engine configuration, and artifacts. A missing prepared pose or unsuitable transformation is a readiness problem—not a reason to invent a free energy estimate.
Track the exact protein structure, construct, cofactors, ligand pose, and preparation context required by the calculation.
Review common scaffold, charge changes, stereochemistry, binding-mode assumptions, and transformation complexity before network design.
Organize pairwise transformations across a congeneric series and retain the graph used to infer relative affinity differences.
Use absolute calculations only with the additional restraints, sampling, and interpretation appropriate to the configured method.
Inspect uncertainty, overlap, convergence, cycle closure, failures, and missing edges before interpreting small numerical differences.
Keep inputs, mapped systems, logs, trajectories or summaries, engine versions, and normalized outputs attached to the project run.
A defensible FEP workflow
Confirm exact structure, binding pose, protonation, cofactors, waters, and series suitability.
Map chemically reasonable transformations and document topology or charge risks.
Execute the configured engine while preserving parameters, progress, failures, and artifacts.
Interpret estimates only after convergence, consistency, and experimental context are considered.
Scientific boundary
Free energy estimates depend on the force field, sampling, protonation and tautomer states, binding mode, water network, protein state, ligand mapping, and convergence. Differences smaller than the relevant uncertainty should not be treated as decisive. Prospective experimental comparison remains essential for assessing the method in each chemical series.
Questions before use
Usually for a congeneric series with a credible shared binding mode and transformations the selected method can represent reliably.
No. It is a model-based estimate with structural, force-field, sampling, and convergence limitations.
They help expose unstable or inconsistent calculations before rank differences are used.
Keep structural prerequisites, mapping, quality diagnostics, and experimental context visible during series decisions.